News

Bicara: Innovative Precision Tumor Targeting
Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...
BVI Medical Announces Approval of Breakthrough Technology: FDA 510(k) Clearance of its Laser Endoscopy Ophthalmic System: Leos™
This clearance marks a significant advancement in glaucoma care, especially for earlier stages of the disease and across a wide spectrum of ...
uniQure jumps on FDA breakthrough tag for Huntington’s disease drug
Qure (QURE) stock surges 39% as FDA grants Breakthrough Therapy designation for AMT-130, a gene therapy for Huntington’s disease. Read more here.
Clearmind Medicine Inc.: Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Spectral Medical Inc.: Spectral Medical Completes Tigris Trial Enrollment
Topline results expected to be released in August 2025Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc.
Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
Spectral Medical Completes Tigris Trial Enrollment
Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.